Marek Roslan

Prof. Dr. Marek Roslan

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Archives of Medical Science
Verified
Journal Article
Open access
SPSławomir Poletajew
Sławomir Poletajew
WKWojciech Krajewski
Wojciech Krajewski
DGDominika Gajewska
Dominika Gajewska
JSJoanna Sondka-Migdalska
Joanna Sondka-Migdalska
MBMichał Borowik
Michał Borowik
KDKonrad Dziobek
Konrad Dziobek
Introduction The aim of the study was to identify predictors of surgical complications of transurethral resection of bladder tumour (TURBT). Material and methods We prospectively recruited 983 consecutive patients undergoing TURBT within seven months in six academic institutions. All...

14 March 2019 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
AYArlette Yumba-Mpanga
Arlette Yumba-Mpanga
WSWiktoria Struck-Lewicka
Wiktoria Struck-Lewicka
RWRenata Wawrzyniak
Renata Wawrzyniak
MRMarek Roslan
Marek Roslan
RKRoman Kaliszan
Roman Kaliszan
RBRenata Bujak
Renata Bujak
Background: In regard to urogenital tract cancer studies, an estimated 340,650 new cases and 58,360 deaths from genital system cancer and about 141,140 new cases and 29330 deaths from urinary system were projected to occur in the United States in 2012. The main drawbacks of currently available diagnostic tests constitute the low specificity, costliness and quite high invasiveness.Objective: The main goal of this pilot study was to determine and compare urine metabolic fingerprints in urogenital tract cancer patients and healthy controls.Method: A comparative analysis of the metabolic profile of urine from 30 patients with cancer of the genitourinary system (bladder (n=10), kidney (n=10) and prostate (n=10)) and 30 healthy volunteers as a control group was provided by LC-TOF/MS and GCQqQ/ MS. The data analysis was performed by the use of U-Mann Whitney test or Student’s t-test, principal component analysis (PCA) and orthogonal partial least-squares discriminant analysis (OPLS-DA).Results: As a result, 33, 43, and 22 compounds were identified as statistically significant in bladder, prostate and kidney cancer, respectively, compared to healthy groups.Conclusion: Diverse compounds such as purine, sugars, amino acids, nucleosides, organic acids which play a role in purine metabolism, in tricarboxylic acid cycle, in amino acid metabolism or in gut microbiota metabolism were identified. Only two metabolites namely glucocaffeic acid and lactic acid were found to be in common in studied three types of cancer.

1 June 2013 in Journal of Endourology
Verified
Journal Article
Closed access
MRMarek Roslan
Marek Roslan
MMMarcin Markuszewski
Marcin Markuszewski
JKJakub Kłącz
Jakub Kłącz
KKKazimierz Krajka
Kazimierz Krajka
Background and Purpose: Various minimally invasive techniques have been developed for bladder diverticulectomy. One of the newest is transvesical laparoendoscopic single-site (T-LESS) surgery. In this article, we present points of technique with initial clinical results after a minimum of 7 months of follow-up. The aim of the study was to assess our first series of patients who underwent T-LESS surgery for transvesical excision of symptomatic bladder diverticula. Patients and Methods: From March 2011 to February 2012, we successfully operated on five men aged 61 to 76 years (mean 66 years) for symptomatic (infections, residual of urine, neoplasm) bladder diverticula, with the use of the T-LESS approach. The procedures were performed using single-port TriPort+, standard laparoscopic instruments, and V-loc suture. All patients underwent follow-up of 6 weeks after surgery and every 3 months thereafter. The follow-up included urine tests, ultrasonography, and cystoscopy when needed. Results: The average operative time was 122 minutes (range 80–175 min), and the blood loss was minimal. Patients were discharged on the third (range 2–4 day) postoperative day with no intra- or postoperative complications. The average 14-month follow-up (range 7–19 mos) confirmed good operative results in all cases. An insignificant small recurrent diverticulum was observed in one patient. The patients did not need transurethral resection of the prostate or reoperation. Conclusions: We consider this technique to be a feasible and safe procedure, and a valuable treatment option for bladder diverticulectomy.

1 September 2013 in Journal of Urology
Verified
Journal Article
Closed access
MRMarek Roslan
Marek Roslan
MMMarcin M. Markuszewski
Marcin M. Markuszewski
The optimal approach for removing surgical materials that have penetrated the bladder is still debatable. We reviewed our initial experience with transvesical (percutaneous intraluminal access) laparoendoscopic single site surgery to treat such complications. We determined the safety, efficacy and morbidity of the procedure. In this case series study 9 women 24 to 63 years old were operated on from November 2009 to July 2012 due to bladder tape/mesh or surgical suture extrusion using the transvesical (percutaneous intraluminal access) laparoendoscopic single site surgery approach. We used the TriPort™ or TriPort+ single site access system, and a combination of straight and articulating or only standard laparoscopic instruments. A running V-Loc™ suture was placed as needed. In all cases followup included urine tests, abdominal ultrasound and cystoscopy. Mean operative time was 59 minutes (range 35 to 105). Median postoperative hospital stay was 2.4 days. No blood loss or complications were observed except 1 conversion to open surgery because of a perivesical abscess. No extra port was added. No adverse events related to the method were observed during the mean 19-month followup. In 1 patient mesh extrusion recurred after 12 months of followup. We consider this technique to be an efficient, safe procedure and a valuable minimally invasive treatment option for foreign body removal from the bladder. However, further observations are needed to prove the validity of the method.

1 September 2012 in Urology
Verified
Journal Article
Closed access
MRMarek Roslan
Marek Roslan
MMMarcin M. Markuszewski
Marcin M. Markuszewski
JKJakub Kłącz
Jakub Kłącz
KKKazimierz Krajka
Kazimierz Krajka

1 August 2012 in Journal of Endourology
Verified
Journal Article
Closed access
MRMarek Roslan
Marek Roslan
MMMarcin M. Markuszewski
Marcin M. Markuszewski
JKJakub Kłącz
Jakub Kłącz
KKKazimierz Krajka
Kazimierz Krajka
Purpose: We present our single-center experience with three patients who were undergoing laparoendoscopic single-site (LESS) diverticulectomy through a single-port device introduced directly into the bladder. Patients and Methods: During March and April 2011, we operated on three men aged 62 to 76 years (mean 67 y) for symptomatic bladder diverticula using a standard lithotomy position and general anesthesia. The procedure was performed transvesically (percutaneous intraluminal approach) with a single-port device (four-channel) via a 1.5-cm incision made 2 cm above the pubic symphysis. Standard 10-mm optic and rigid laparoscopic instruments were used. The defect of the bladder wall was closed with an absorbable 3/0 running V-Loc suture. An 18F Foley catheter was left for 4 to 7 days. Results: The average operative time was 128 minutes (range 80–175 min). The blood loss was minimal. Patients were discharged on the third postoperative day with no intra-, nor postoperative complications. The 3-month follow-up confirmed good operative results in all cases. Conclusion: We consider laparoendoscopic single-port transvesical excision of bladder diverticulum as a feasible and safe procedure and a valuable treatment option for bladder diverticulectomy.